# Curadim Pharma Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/curadim-pharma-co

- Industry: Pharmaceuticals
- Headquarters: Tokyo, Japan
- Website: www.curadim.co.jp/en
- Total disclosed funding: $11M
- Latest round: Series B (Jun 4, 2018)
- Investors on record: 8

## About

Founded in 2016 and based in Tokyo, Japan, Curadim Pharma Co., Ltd. is specialised in researching and developing pharmaceutical products. It focuses on unmet medical needs in the immune field of the market.

## Funding rounds

- Series B, Jun 4, 2018, $11M — INCJ, SMBC Venture Capital, DBJ Capital, YMFG Capital
- Series A, Aug 4, 2016 — Nippon Venture Capital, INCJ, Mitsubishi UFJ Capital, SMBC Venture Capital, Nissay Capital, Meiji Seika Pharma

## Investors

- Nippon Venture Capital (https://capitalatlas.ai/funds/nippon-venture-capital) — Series A
- INCJ — Series A, Series B
- Mitsubishi UFJ Capital (https://capitalatlas.ai/funds/mitsubishi-ufj-capital) — Series A
- SMBC Venture Capital (https://capitalatlas.ai/funds/smbc-venture-capital) — Series A, Series B
- Nissay Capital (https://capitalatlas.ai/funds/nissay-capital) — Series A
- Meiji Seika Pharma — Series A
- DBJ Capital (https://capitalatlas.ai/funds/dbj-capital) — Series B
- YMFG Capital (https://capitalatlas.ai/funds/ymfg-capital) — Series B